Effect of angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy.
Bannister
K M
KM
Renal Unit, Royal Adelaide Hospital, Australia.
Weaver
A
A
Clarkson
A R
AR
Woodroffe
A J
AJ
D000450:Aldosterone / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D003131:Combined Modality Therapy; D004039:Diet, Sodium-Restricted; D018450:Disease Progression; D004656:Enalapril / Q000494:pharmacology / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005922:Glomerulonephritis, IGA / Q000097:blood / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy*; D006801:Humans; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use*; D011446:Prospective Studies; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology; D012079:Renal Circulation / Q000187:drug effects; D012083:Renin / Q000097:blood; D016896:Treatment Outcome; D014655:Vascular Resistance / Q000187:drug effects
D000450:Aldosterone; D004656:Enalapril; D012083:Renin; D009543:Nifedipine